<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ofloxacin (otic): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ofloxacin (otic): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Ofloxacin (otic): Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="12271" href="/d/html/12271.html" rel="external">see "Ofloxacin (otic): Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="16030" href="/d/html/16030.html" rel="external">see "Ofloxacin (otic): Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F9498000"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Fluoroquinolone;</li>
<li>
                        Antibiotic, Otic</li></ul></div>
<div class="block doa drugH1Div" id="F9497841"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f5d6908b-d92c-483f-9021-2db65a1a0811">Otitis externa, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis externa, acute:</b>
<b>Otic:</b> Instill 10 drops into affected ear(s) once daily for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-manu.1'])">Ref</a></span>); may extend an additional 7 days if symptoms are improving but not yet resolved (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24491310']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24491310'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="585aba02-b527-46f3-8df1-498ca86f1b1f">Otitis media, chronic suppurative</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, chronic suppurative (with perforated tympanic membranes):</b>
<b>Otic:</b> Instill 10 drops into affected ear(s) twice daily for 14 days.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991760"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doha drugH1Div" id="F50988944"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block dop drugH1Div" id="F9497840"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="16030" href="/d/html/16030.html" rel="external">see "Ofloxacin (otic): Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f5d6908b-d92c-483f-9021-2db65a1a0811">Otitis externa, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis externa, acute: </b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥6 months and Children: Otic: Instill 5 drops (0.25 mL) into the affected ear(s) once daily for 7 days.</p>
<p style="text-indent:-2em;margin-left:4em;">Adolescents: Otic: Instill 10 drops (0.5 mL) into the affected ear(s) once daily for 7 days.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (with tympanostomy tubes):</b> Children: Otic: Instill 5 drops (0.25 mL) into the affected ear(s) twice daily for 10 days.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="585aba02-b527-46f3-8df1-498ca86f1b1f">Otitis media, chronic suppurative</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, chronic suppurative (with perforated tympanic membranes):</b> Children ≥12 years and Adolescents: Otic: Instill 10 drops (0.5 mL) into the affected ear(s) twice daily for 14 days.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51131686"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Infants ≥6 months, Children, and Adolescents: There are no dosing adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51131687"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Infants ≥6 months, Children, and Adolescents: There are no dosing adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F9497564"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Reported adverse reactions are for adults and pediatric patients.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Local: Application-site reaction (≤17%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Pruritus (1% to 4%), skin rash (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Dysgeusia (7%)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness (≤1%), paresthesia (1%), vertigo (≤1%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Flushing, hypertension, tachycardia</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Dermatitis, eczema, erythematous rash, follicular rash, seborrhea, urticaria</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Hot flash</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, halitosis, nausea, vomiting, xerostomia</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Fungal infection</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dysesthesia, headache, hypoesthesia, tremor</p>
<p style="text-indent:-2em;margin-left:4em;">Otic: Bleeding from ear, tinnitus</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Cough, pharyngitis, rhinitis, sinusitis</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Nervous system: Psychiatric disturbance (transient)</p></div>
<div class="block coi drugH1Div" id="F9497552"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to ofloxacin, other quinolones, or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F9497553"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Severe hypersensitivity reactions (some fatal), including anaphylaxis, have occurred (some following the first does) with systemic fluoroquinolone therapy. Prompt discontinuation of drug should occur if skin rash or other symptoms of hypersensitivity arise.</p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection. If superinfection occurs, discontinue use and institute appropriate alternative therapy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Tendon inflammation/rupture: There have been reports of tendon inflammation and/or rupture with systemic fluoroquinolones. Exposure following otic administration is substantially lower than with systemic therapy. Discontinue at first sign of tendon inflammation or pain.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For otic use only; not for injection or for ophthalmic use. If infection is not improved after 1 week, consider culture to identify organism. Avoid contaminating the bottle tip with material from the ear, fingers, or other source.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878753"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">In pediatric patients, use of quinolone ear drops may increase the risk of tympanic rupture. A retrospective cohort study of over 96,000 patients (&lt;18 years of age) compared patients who received a quinolone-containing ear drop (n=78,275) to those who received a neomycin plus hydrocortisone ear drop (n=18,320). Patients who received quinolone ear drops after tympanostomy tube placement had an increased incidence of tympanic perforation requiring tympanoplasty with an adjusted hazard ratio of 1.61 (95% confidence interval [CI]: 1.15 to 2.26); combination products containing corticosteroids may amplify adverse effect risk (Alrawisan 2017).</p>
<p style="text-indent:0em;margin-top:2em;">In another retrospective cohort study of patients with acute otitis externa comparing patients who received quinolone-containing otic drops (n=35,851 pediatric and 7,802 adult) to those who received neomycin with hydrocortisone otic drops (n=32,753 pediatric and 17,927 adult), it was reported that patients who received quinolone-containing ear drops had an increased risk of tympanic membrane perforation with an adjusted hazard ratio of 2.19 (95% CI: 1.01 to 4.73); ofloxacin specifically was associated with an adjusted hazard ratio of 2.53 (95% CI: 1.27 to 5.05) (Wang 2020). Monitor and counsel patients accordingly.</p></div>
<div class="block foc drugH1Div" id="F9497976"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Otic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.3% (5 mL, 10 mL)</p></div>
<div class="block geq drugH1Div" id="F9496349"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F9497978"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ofloxacin Otic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.3% (per mL): $30.86 - $31.47</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F9497905"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">For otic use only; not for injection, inhalation, or topical ophthalmic use. Prior to use, warm solution by holding container in hands for 1 to 2 minutes. Patient should lie down with affected ear upward and medication instilled. Patients should remain in this position for 5 minutes to allow penetration of solution; repeat if necessary for the opposite ear. For traumatic tympanic membrane closure (off-label use), patient should remain lying down in a lateral position with the injured ear up for 30 minutes after instillation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27105974']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27105974'])">Ref</a></span>). For acute otitis media and chronic suppurative otitis media, pump tragus 4 times to ensure penetration of medication.</p></div>
<div class="block admp drugH1Div" id="F52614391"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Otic: For otic use only; not for oral use, ophthalmic use, or injection. Gently clean any discharge that can be easily removed from the outer ear. Warm otic solution by holding bottle in hand for 1 to 2 minutes prior to instillation. The tip of the bottle should not touch the fingers, ear, or any surface. Patient should lie on side with affected ear upward. For middle ear infections, gently press the tragus 4 times in a pumping motion to allow the drops to pass through the hole or tube in the eardrum and into the middle ear. For otitis externa infection, pull the outer ear upward and backward to allow the ear drops to flow down into the ear canal. Patient should remain on his/her side for at least 5 minutes. If necessary, repeat procedure for the other ear.</p></div>
<div class="block use drugH1Div" id="F9496350"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis externa, acute:</b> Treatment of otitis externa due to susceptible isolates of <i>Escherichia coli</i>, <i>Pseudomonas</i>
<i> aeruginosa</i>, and <i>Staphylococcus</i>
<i> aureus </i>in adults and pediatric patients 6 months and older.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute</b>: Treatment of acute otitis media with tympanostomy tubes due to susceptible isolates of <i>S. aureus</i>, <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i>, <i>Moraxella catarrhalis</i>, and <i>P. aeruginosa</i> in pediatric patients 1 year and older.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, chronic suppurative</b>: Treatment of chronic supportive otitis media with perforated tympanic membranes due to susceptible isolates of <i>Proteus mirabilis</i>, <i>P. aeruginosa</i>, and <i>S. aureus</i> in patients 12 years and older.</p></div>
<div class="block mst drugH1Div" id="F9496297"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Floxin may be confused with Flexeril</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">International issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Floxin: Brand name for ofloxacin [US], but also the brand name for flunarizine [Thailand], norfloxacin [South Africa], and perfloxacin [Philippines]</p>
<p style="text-indent:-2em;margin-left:4em;">Floxin [US] may be confused with Flexin brand name for diclofenac [Argentina], cyclobenzaprine [Chile], and orphenadrine [Israel]; Flogen brand name for naproxen [Mexico]</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F9497665"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F9497666"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F9775942"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events have been observed in some animal reproduction studies. When administered orally, ofloxacin crosses the placenta (Giamarellou 1989). The amount of ofloxacin available systemically following topical application of the otic drops is significantly less in comparison to oral doses. </p></div>
<div class="block brc drugH1Div" id="F9497551"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">When administered orally, ofloxacin enters breast milk. It is not known if ofloxacin can be detected in breast milk following otic administration. Due to the potential for serious adverse reactions in the nursing infant, the manufacturer recommends a decision be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother.</p></div>
<div class="block pha drugH1Div" id="F9497805"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Inhibits DNA-Gyrase in susceptible organisms; bactericidal.</p></div>
<div class="block phk drugH1Div" id="F9775940"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Absorption: Only small amounts are absorbed systemically after otic instillation.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F14721645"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Oflox | Optiflox</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Newflox | Oflox | Ofloxacina | Otoflox | Rafocilina</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Ofloxacin pos | Ofloxacin Stulln</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Ocuflox</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Obactin | Vista</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Ofloxacin pos | Trafloxal</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Exocine</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Uniflox</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Genoxacin | Nostil | Oflox | Ofloxacino</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Floxal</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Oflacin</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Oflox</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">An li | Ao fu xing | Di ke luo | Dong kang ming | Fu er bi tuo | Heng run | Nuo qing | Tarivid | Xin li tuo | Yuan qing</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Oflaxsyn | Oflox</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Ofloxacin pos</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Ofloxa vision | Ofloxacin pos | Ofloxacin Ratiopharm | Ofloxacin Stulln | Ofloxamed</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Maxifloxina | Neofloxin | Oflox | Otoflox</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Oflox | Otoflox</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Occufloxin | Ocuflox | Ocufloxine | Oflicin | Oflox | Ofloxin | Optiflox | Quifluro | Tariflox</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Exocin | Ofloxacino pos</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Ofloxacine | Ofus | Oxop</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Exocin</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Exocine</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Exocin</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Exocin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Aflacin | Apo-Ofloxacin | Earflo | Lycoxacin | Ofloxal | Ofus | Otra | Tarivid</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Uniflox</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Ofloxacin unimed pharma</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Akilen | Floxa | Forotic | Koniflox | Tarivid | Zelavel</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Exocin</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Oflo avenir | Oflox</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Alof | Auroflox | Bell ofc | Emucin | Entof | Exocin | Flan | Floxil-o | Foxin | Galoxin | Gbo | Obid | Ocucin | Oculone | Ofal | Ofax | Ofbid | Ofil | Oflacin | Oflo | Ofloren | Oflostar | Oflotas | Oflox | Oflozen | Ofray | Ofron | Ojen | Olox | Omeflox | Otoflox | Oxo | Oxop | Quinoflox | Say o flox | Seaflox | Sioflox | T-flox | Tariflox | Tisol | Zanocin | Zanoflox | Zenflox | Zeof | Zynoff</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Pioflox</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Eukinoft | Exocin | Floxigen | Multifloxofta | Visuab</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Oflox | Optiflox</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Libiget | Marromel | Ofloxacin kyorin | Ofloxat | Ofloxin | Oftector | Oharaxin | Olcavit | Opool | Pharxacin | Pharxacin kowa | Pharxacin mita | Tarifron | Tarivid | Tarivid santen | Tarixacin | Tarizart | Xatron</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Auroflox | Exocin | Eyforex | Hipoflox | Ocuflox</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Aflox | Bearofl | Effexin | Eyepro | Flacin | Fugacin | Huflox | Huons ofloxacin | Latacin | Light ofl | Luce o | Mp ofloxacin | Obide | Octacin | Ocucin | Ocuflox | Ofaxin | Ofbella | Oflan | Oflocin | Oflone | Oflox | Ofloxat | Ofloxin | Ofltwo | Ofolo | Ofrox | Ofuain | Ofueyen | Ofuran | Ofus | Oloxacin | Operan | Optipro | Oraloxin | Orocin | Orovit | Otra | Oxacin | Praxin | Quiloxin | Quinovid | Reoflox | Superox | Tariflox | Tarivid | Tarivid otic | Telvit | Vioflox</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Oflicin | Oflox | Optiflox</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Floxigen | Oflex | Oflocol | Oflox | Optiflox</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Uniflox</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Ofloxacin pos</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Uniflox</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Exocine | Floxedol | Visof</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Ocuflox</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Effexin | Tarivid</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">La lid ofloxacin</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Ofloxacine Pos | Ofloxacine Sandoz | Trafloxal</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Oflox | Tructum</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Celsus Ofloxacin | Cinoflox | Dizoflox | Exogan | Iflox | Inoflox | Iquinol | Ofbeat | Oflomax | Otocin | Otoflox | Ponebac | Sensoflox</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Altaflox | Ciof | Exocin | Flobacin | Floxy | Kunoxy | Medioflox | Oflexer | Oflobiotic | Oflocin | Ofloquin | Oflotek | Ofly-v | Ofvin | Ophth-Flox | Optiquin | Optoflox | Optoflox Plus | Otoflox | Taricin | Tariflox | Uniflox | Veflox</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Oflodinex | Ofloxacin pos | Ofloxamed</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Floxin otic | Floxin otic singles | Ocuflox</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Exocin | Floxedol | Ottoflox</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Otonil</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Uniflox</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Dancil | Floxal | Ofloxacin solopharm | Uniflox</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Oflox | Optiflox | Oxacin</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Tarivid otic</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Uniflox</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Tarivid</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Exocine | Oflocet | Oflocol | Oflocol 3m</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Exocin | Girasid | Zaridinex</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Earflo | Oflovid | Ofloxin | Tarivid</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Floxal | Floxanext | Uniflox</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Floxacin | Oflox | Quinomed</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Oflox</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Bi otra | Floxadrop | Gifloxin | Octavic | Oxciu | Vifloxacol</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Exocin | Octin | Ocuflox | Zo eye/ear drops</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Exocin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-28329128">
<a name="28329128"></a>Alrwisan A, Antonelli PJ, Winterstein AG. Quinolone ear drops after tympanostomy tubes and the risk of eardrum perforation: a retrospective cohort study. <i>Clin Infect Dis</i>. 2017;64(8):1052-1058.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ofloxacin-otic-drug-information/abstract-text/28329128/pubmed" id="28329128" target="_blank">28329128</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Floxin (ofloxacin) [prescribing information]. Pine Brook, NJ: Almatica Pharma Inc.; July 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2589353">
<a name="2589353"></a>Giamarellou H, Kolokythas E, Petrikkos G, et al. "Pharmacokinetics of Three Newer Quinolones in Pregnant and Lactating Women," Ciprofloxacin: major advances in intravenous and oral quinolone therapy. Proceedings of a symposium. April 28 to 29, 1989, Naples, Florida.<i> Am J Med</i>. 1989; 87(5A):49S-51S.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ofloxacin-otic-drug-information/abstract-text/2589353/pubmed" id="2589353" target="_blank">2589353</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27105974">
<a name="27105974"></a>Jian-Yang, Zi-Han-Lou, Yahui-Fu, Zheng-Cai-Lou. A retrospective study of EGF and ofloxacin drops in the healing of human large traumatic eardrum perforation. <i>Am J Otolaryngol</i>. 2016;37(4):294-298.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ofloxacin-otic-drug-information/abstract-text/27105974/pubmed" id="27105974" target="_blank">27105974</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Ofloxacin otic solution [prescribing information]. Bridgewater, NJ: Amneal Pharmaceuticals LLC; October 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer’s labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24491310">
<a name="24491310"></a>Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. <i>Otolaryngol Head Neck Surg</i>. 2014;150(1 suppl):S1-S24. doi:10.1177/0194599813517083<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ofloxacin-otic-drug-information/abstract-text/24491310/pubmed" id="24491310" target="_blank">24491310</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31044229">
<a name="31044229"></a>Wang X, Winterstein AG, Alrwisan A, Antonelli PJ. Risk for Tympanic Membrane Perforation After Quinolone Ear Drops for Acute Otitis Externa. <i>Clin Infect Dis</i>. 2020;70(6):1103-1109.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ofloxacin-otic-drug-information/abstract-text/31044229/pubmed" id="31044229" target="_blank">31044229</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9891 Version 203.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
